Autumn Glory Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
9,222
+122
+1% +$14.1K 0.41% 62
2025
Q4
$958K Buy
9,100
+1,338
+17% +$126K 0.34% 81
2025
Q3
$652K Buy
7,762
+26
+0.3% +$2.14K 0.27% 103
2025
Q2
$612K Sell
7,736
-405
-5% -$32.2K 0.29% 95
2025
Q1
$731K Hold
8,141
0.36% 83
2024
Q4
$810K Sell
8,141
-1,754
-18% -$181K 0.4% 70
2024
Q3
$1.12M Buy
9,895
+1,145
+13% +$136K 0.43% 67
2024
Q2
$1.08M Sell
8,750
-1,189
-12% -$153K 0.55% 57
2024
Q1
$1.31M Hold
9,939
0.64% 51
2023
Q4
$1.15M Sell
9,939
-655
-6% -$68K 0.65% 48
2023
Q3
$1.09M Buy
10,594
+1,032
+11% +$111K 0.67% 50
2023
Q2
$1.1M Sell
9,562
-1,985
-17% -$225K 0.81% 43
2023
Q1
$1.23M Sell
11,547
-93
-0.8% -$10K 1.05% 27
2022
Q4
$1.29M Buy
11,640
+1,885
+19% +$193K 0.69% 47
2022
Q3
$840K Sell
9,755
-2,377
-20% -$212K 0.57% 60
2022
Q2
$1.11M Buy
12,132
+1,000
+9% +$88.7K 0.82% 41
2022
Q1
$913K Sell
11,132
-4,256
-28% -$336K 0.53% 70
2021
Q4
$1.18M Buy
+15,388
New +$1.23M 0.49% 59

Other funds holding MRK

Autumn Glory Partners's MRK Position: Q1 2026 in Review

Autumn Glory Partners increased its Merck (MRK) stake by 1.3% in Q1 2026, buying an estimated $14.1K and bringing the position to 9,222 shares worth $1.11M. The position accounts for 0.41% of the portfolio, ranked #62.

Autumn Glory Partners first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.31M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Autumn Glory Partners held 9,222 shares of Merck worth $1.11M as of Q1 2026.
  • Autumn Glory Partners bought 122 Merck shares in Q1 2026, an estimated $14.1K.
  • Merck made up 0.41% of Autumn Glory Partners's portfolio in Q1 2026, its #62 holding.
  • Autumn Glory Partners first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Autumn Glory Partners's Merck position peaked at $1.31M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Autumn Glory Partners's 13F filing for Q1 2026, filed 4 May 2026.